Wed 21 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Methotrexate | Metoject | 4.6 Fertility, pregnancy and lactation | Jul, 2025 |
| Rosuvastatin,Ezetimibe | Lipocomb | 4.5. Interactions with other medicinal products | Jul, 2024 |
| Insulin Degludec,Liraglutide | Xultophy | 4.8 Undesirable effects | Jul, 2024 |
| Cadribine | Mavenclad | 4.5. Interactions with other medicinal products | Feb,2023 |
| Insulin Glargine/Lixisenatide | Soliqua Solostar | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Belimumab | Benlysta | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Fluvastatin | Lescol XL | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Feb,2023 |
| Rosuvastatin | Crestor | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Feb,2023 |
| Semaglutide | Rybelsus | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Tobramycin Inhalation Solution | Tobi Podhaler | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
Last update date: 04/10/2026 at 10:24 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.